Condition: Cerebral Palsy (CP) · Sponsor: IRCCS Eugenio Medea
The goal of this clinical trial is to learn if a two month training with the Agilik powered orthosis improves the knee extension or the endurance in pediatric patients with Cerebral palsy and a crouch gait. It will also learn about the safety of Agilik. The main questions it aims to answer are: Does the Agilik powered orthosis increase the value of the knee extension during walking? What medical problems do participants have when using the Agilik powered orthosis? Researchers will compare a group of patients using the Agilik powered exoskeleton with a group of patients treated with standard therapy. Participants will: Use Agilik at home or perform standard therapy for 2 months Visit the clinic at the beginning of the study, after 3 months and after 1 additional month.
This description comes directly from the study's public registry record.
Emilia Biffi, PhD · +39031877862 · emilia.biffi@lanostrafamiglia.it
Cristina Maghini, MD · cristina.maghini@lanostrafamiglia.it
Always discuss trial participation with your own doctor first.
| IRCCS E. MEDEA - Associazione "La Nostra Famiglia" | Bosisio Parini, Lecco, Italy | Recruiting |
| IRCCS Fondazione Stella Maris | Calambrone, Pisa, Italy | Not Yet Recruiting |
| Fondazione Don Carlo Gnocchi Onlus - IRCCS S. Maria Nascente | Milan, Italy | Recruiting |
| Fondazione Mondino | Pavia, Italy | Not Yet Recruiting |
| Fondazione Don Carlo Gnocchi Onlus | Roma, Italy | Recruiting |
| Fondazione Don Carlo Gnocchi Onlus - Centro S. Maria al Mare | Salerno, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06622655